Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
syMMPonia Study: Linvemastat in Partially Controlled Asthma
NCT07191535Phase 2Not yet recruiting
- Sponsor
- Foresee Pharmaceuticals
- Start
- Mar 2027
- Primary completion
- Jan 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of linvemastat in asthma, sponsored by Foresee Pharmaceuticals. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
linvemastat
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07191535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07191535.